Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 3,555.00
-40.00 (-1.11%)
At close: Oct 23, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 24.95 billion as of October 23, 2026. It is the 37,310th most valuable company in the world and the 2,285th biggest in South Korea. Its market cap has decreased by 27.52% in one year.
Market Cap
24.95B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,285 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 24.95B, a decrease of -69.87%. That is a compound annual growth rate of -24.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 24.95B | -25.63% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korean Drug | 33.72B |
| Korea Arlico Pharm | 32.65B |
| HLscience | 28.16B |
| Pharmsville | 26.70B |
| Seoul Pharma | 22.19B |
| BIFIDO | 21.68B |
| Daesung Microbiological Labs. | 21.55B |
| Union Korea Pharm | 19.70B |